MannKind | MNKD - 当期純利益





当期純利益 変化する 日付
Adma Biologics USD 49.38M 12.95M 2025-12
BioCryst Pharmaceuticals USD 245.84M 232.95M 2025-12
Eli Lilly USD 6.64B 1.05B 2025-12
Halozyme Therapeutics USD -141.59M 316.82M 2025-12
Insmed USD -328.48M 41.54M 2025-12
Karyopharm Therapeutics USD -30.78M 1.29M 2024-12
MacroGenics USD -14.16M 30.98M 2025-12
MannKind USD -15.95M 23.93M 2025-12
Merck USD 2.96B 2.82B 2025-12
Minerva Neurosciences USD 1.44M 21.07M 2024-12
Novavax USD 17.53M 219.91M 2025-12
Novo Nordisk DKK 4.03B 25.01B 2025-06
Pfizer USD -1.65B 5.19B 2025-12
Sanofi EUR -801M 3.6B 2025-12
Xencor USD -6.65M 626K 2025-12